Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01445158 · ClinicalTrials.gov registry record

Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
19
Enrollment target

NCT01445158: Completed study, sponsored by National Cancer Institute (NCI).

NCT01445158 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01445158 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
19 participants
Enrollment target

Study Summary

Background: * Hematopoietic Stem Cell Transplant (HSCT) represents the second most frequent major organ transplant in the United States. * Pediatric 1st degree stem cell donors can experience a variety of psychological difficulties before and after donation with those who feel they are not adequately prepared for possible complications following stem cell donation and transplant describing negative emotions. * The importance of preparation for children undergoing medical procedures has long been recognized in the field of pediatric psychology Objectives: * To assess how prepared pediatric donors are for stem cell donation by assessing their knowledge about stem cell transplants, and to assess their anxiety at different stages of the donation process. * To assess the effectiveness of a workbook and a board game as tools for conveying information on donation and transplantation to donors. * To identify donors who may require additional preparation before stem cell collection. * To explore the relationship between donor knowledge and anxiety symptoms. Eligibility: -Stem cell donors ages 10 to 26 years of age Design: * Participant s baseline knowledge and anxiety are evaluated. * Participant s knowledge is reassessed and anxiety evaluated following an information session with the research nurse and doctor about the procedures for stem cell donation and discussion of the consent form for the transplant protocol. * Participants are separated into two groups. Donors 10 to 15 years of age play a board game; those 16 to 26 years of age are given a workbook on stem cell transplant. * Participants knowledge and anxiety are reassessed within 24 hours after working with the educational materials and again 1 month later.

Primary Outcome

results of donor quiz and anxiety assessment

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2007-06-18
Est. Completion 2020-05-04
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT01445158 record still lists

NCT01445158 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01445158 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01445158 about?

NCT01445158 is a clinical study titled "Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures". Background: * Hematopoietic Stem Cell Transplant (HSCT) represents the second most frequent major organ transplant in the United States. * Pediatric 1st degree stem cell donors can experience a variety of psychological difficulties before and after donation with those who feel they are not adequate...

What is the current status of trial NCT01445158?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2007-06-18. Estimated completion is 2020-05-04.

Who is sponsoring clinical trial NCT01445158?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01445158, the US trial registry maintained by the National Library of Medicine. NCT01445158 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.